-
Areas
Technologies
  • Metabolomic analysis
  • Diagnostics
  • Transcriptomics
  • Clinical trials
  • Cohort studies
  • Cohort analysis
  • Mathematical modelling
Themes / Divisions

About

We aim to study malaria host-parasite interactions with a particular focus on gaining a better understanding of:
* Differential patterns of natural acquisition of immune responses and their association with parasite exposure and protection from infection.
* Parasite dynamics within the human host and the genetic diversity and evolutionary history of parasites.
* Transmission epidemiology and biology of Plasmodium gametocytes and sporozoites.
* Host immune responses to Plasmodium infection and how they relate to exposure history and protection against clinical disease
* The role of hypnozoite in the increase resilience of P. vivax to control and elimination.
* Host genetic adaptation to malaria.

These questions are being addressed with a range of population-based studies in malaria-affected regions of Papua New Guinea, the Solomon Islands, Thailand, Cambodia and Brazil that combine well-designed epidemiological and clinical studies with in-depth molecular, immunological and systems biology studies of host-parasite interactions.

More recently we have extended into studying COVID-19 infection. Leveraging our experience from malaria serology, we have developed novel approached to COVID-19 sero-surveillance and are studying the acquisition and maintenance of immunity to SARS-CoV-2 infections.

In parallel, we are supporting health authorities in the Pacific with planning for and managing the COVID-19 pandemic by modelling different SARS-CoV-2 transmission scenarios and development of analytical tools to monitor the local progression of the pandemic.

Publications

Selected publications from Prof Ivo Mueller

Hu S, Wang F, Huang Q, Chen Y, Lyu D, Zhou N, Wang M, Zhang M, Xu C, Mueller I, Yao G, Liu X, Zhang Q, Hong W. Eveningness is associated with more severe depressive symptoms independently of sleep quality and fatigue level only in first-episode but not recurrent depression in major depressive disorder. Chronobiology International. 2024;ahead-of-print(ahead-of-print):10.1080/07420528.2024.2378958

Kosasih A, Utami RAS, Noviyanti R, Elyazar IRF, Lestari KD, Raimanus VS, Longley RJ, Baird JK, Robinson LJ, Sutanto I, Mueller I. Agreement between serological data on schoolchildren and the number of malaria cases in the remaining high-burden villages of Indonesia. Frontiers in Malaria. 2024;2:10.3389/fmala.2024.1362585

Mitchell RA, Ubillos I, Requena P, Campo JJ, Ome-Kaius M, Hanieh S, Umbers A, Samol P, Barrios D, Jiménez A, Bardají A, Mueller I, Menéndez C, Rogerson S, Dobaño C, Moncunill G. Chronic malaria exposure is associated with inhibitory markers on T cells that correlate with atypical memory and marginal zone-like B cells. Clinical & Experimental Immunology. 2024;216(2):10.1093/cei/uxae015

Le TP, Abell I, Conway E, Campbell PT, Hogan AB, Lydeamore MJ, McVernon J, Mueller I, Walker CR, Baker CM. Modelling the impact of hybrid immunity on future COVID-19 epidemic waves. BMC Infectious Diseases. 2024;24(1):10.1186/s12879-024-09282-4

Pepey A, Souris M, Kim S, Obadia T, Chy S, Ea M, Ouk S, Remoue F, Sovannaroth S, Mueller I, Witkowski B, Vantaux A. Comparing malaria risk exposure in rural Cambodia population using GPS tracking and questionnaires. Malaria Journal. 2024;23(1):10.1186/s12936-024-04890-6

Anwar N, Smith L, Devine A, Mehra S, Walker CR, Ivory E, Conway E, Mueller I, McCaw JM, Flegg JA, Hickson RI. Mathematical models of Plasmodium vivax transmission: A scoping review. PLOS Computational Biology. 2024;20(3):10.1371/journal.pcbi.1011931

Grimée M, Tacoli C, Sandfort M, Obadia T, Taylor AR, Vantaux A, Robinson LJ, Lek D, Longley RJ, Mueller I, Popovici J, White MT, Witkowski B. Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia. Malaria Journal. 2024;23(1):10.1186/s12936-024-04859-5

Commons RJ, Rajasekhar M, Edler P, Abreha T, Awab GR, Baird JK, Barber BE, Chu CS, Cui L, Daher A, Gonzalez-Ceron L, Grigg MJ, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Lidia K, Llanos-Cuentas A, Longley RJ, Pereira DB, Pasaribu AP, Pukrittayakamee S, Rijal KR, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, Watson JA, Zuluaga-Idarraga LM, White NJ, Guerin PJ, Simpson JA, Price RN, Efficacy TASSGWARNVPD, Adhikari B, Anstey NM, Assefa A, Boyd SC, Chau NH, Day NP, Degaga TS, Dondorp AM, Erhart A, Ferreira MU, Ghimire P, Green JA, Koh GC, Mekuria AH, Mueller I, Naadim MN, Nelwan EJ, Nosten F, Price DJ, Sattabongkot J, Stepniewska K, von Seidlein L, William T, Woodrow CJ, Woyessa A. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases. 2024;24(2):10.1016/s1473-3099(23)00430-9

Naung MT, Martin E, Wong W, Razook Z, Utama D, Guy AJ, Harrison ST, Cowman AF, Lin E, Kiniboro B, Laman M, Mueller I, Barry AE. Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea. Frontiers in Parasitology. 2023;2:10.3389/fpara.2023.1288867

Barua P, Duffy MF, Manning L, Laman M, Davis TME, Mueller I, Haghiri A, Simpson JA, Beeson JG, Rogerson SJ. Antibody to Plasmodium falciparum Variant Surface Antigens, var Gene Transcription, and ABO Blood Group in Children With Severe or Uncomplicated Malaria. The Journal of Infectious Diseases. 2023;228(8):10.1093/infdis/jiad217

Lab research projects

Interested in supporting our research?

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Contact our friendly team to find out how you can help.